DK2283154T3 - MAL- og CADM1-promotormethylering, molekylær diagnostisk markør for HPV-inducerede invasive livmoderhalscancere samt deres forstadielæsioner med høj malignitet - Google Patents

MAL- og CADM1-promotormethylering, molekylær diagnostisk markør for HPV-inducerede invasive livmoderhalscancere samt deres forstadielæsioner med høj malignitet

Info

Publication number
DK2283154T3
DK2283154T3 DK09732836.3T DK09732836T DK2283154T3 DK 2283154 T3 DK2283154 T3 DK 2283154T3 DK 09732836 T DK09732836 T DK 09732836T DK 2283154 T3 DK2283154 T3 DK 2283154T3
Authority
DK
Denmark
Prior art keywords
hpv
mal
well
diagnostic marker
molecular diagnostic
Prior art date
Application number
DK09732836.3T
Other languages
English (en)
Inventor
Petrus Josephus Ferdinandus Snijders
Christophorus Joannes Lambertus Maria Meijer
Renske Daniela Maria Steenbergen
Original Assignee
Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg filed Critical Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg
Application granted granted Critical
Publication of DK2283154T3 publication Critical patent/DK2283154T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/125Bisulfite(s)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK09732836.3T 2008-04-14 2009-04-14 MAL- og CADM1-promotormethylering, molekylær diagnostisk markør for HPV-inducerede invasive livmoderhalscancere samt deres forstadielæsioner med høj malignitet DK2283154T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08154496 2008-04-14
PCT/NL2009/050194 WO2009128714A1 (en) 2008-04-14 2009-04-14 Mal, a molecular diagnostic marker for hpv-induced invasive cancers and their high-grade precursor lesions

Publications (1)

Publication Number Publication Date
DK2283154T3 true DK2283154T3 (da) 2013-08-26

Family

ID=39718999

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09732836.3T DK2283154T3 (da) 2008-04-14 2009-04-14 MAL- og CADM1-promotormethylering, molekylær diagnostisk markør for HPV-inducerede invasive livmoderhalscancere samt deres forstadielæsioner med høj malignitet

Country Status (12)

Country Link
US (1) US9315866B2 (da)
EP (1) EP2283154B1 (da)
JP (1) JP5584197B2 (da)
CN (1) CN102105595A (da)
AU (1) AU2009236789B2 (da)
CA (1) CA2721356C (da)
DK (1) DK2283154T3 (da)
ES (1) ES2425617T3 (da)
HR (1) HRP20130780T1 (da)
NZ (1) NZ588618A (da)
PT (1) PT2283154E (da)
WO (1) WO2009128714A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2521914A4 (en) * 2010-01-08 2013-07-10 Oncohealth Corp CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER
CA2848654C (en) * 2011-09-15 2021-07-20 Self-Screen B.V. Methylation analysis on self-samples as triage tool for hpv-positive women
AU2012347522B2 (en) * 2011-12-08 2015-07-30 Five3 Genomics, Llc MDM2-containing double minute chromosomes and methods therefore
WO2013130517A1 (en) * 2012-02-27 2013-09-06 The Johns Hopkins University Dna hypermethylation of promoters of target genes and clinical diagnosis and treatment of hpv related disease
WO2013144344A2 (en) * 2012-03-30 2013-10-03 Istituto Europeo Di Oncologia S.R.L. Biomarkers for hpv infections, related diagnostic methods and kits
PT2906716T (pt) * 2012-10-12 2018-04-13 Self Screen Bv Hsa-mir124 e fam19a4, marcadores moleculares de diagnóstico para cancros invasivos induzidos por hpv e suas lesões precursoras de alto grau
KR20160133293A (ko) * 2015-05-12 2016-11-22 에이비온 주식회사 Hpv 바이러스의 발암 유전자 발현 저해물질을 유효성분으로 포함하는 암세포 감작용 조성물
EP3135768A1 (en) * 2015-08-26 2017-03-01 Self-screen B.V. Zic1 and ghsr, molecular diagnostic markers for hpv-induced invasive cancers, nonhpv-induced gynaecological and anogenital cancers and their high-grade precursor lesions
WO2017040491A1 (en) 2015-08-31 2017-03-09 The United States Of America As Represented By The Secretary Of The Army Methods for molecularly characterizing cervical cell samples
CN107328620B (zh) * 2017-06-23 2020-06-05 浙江普罗亭健康科技有限公司 用于流式细胞技术的封闭缓冲液及试剂盒
CN113677361A (zh) * 2018-12-28 2021-11-19 株式会社Neogentc 包含表达mal的干细胞样记忆t细胞作为活性成分的免疫增强或抗癌活性增强的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE382099T1 (de) * 2003-03-31 2008-01-15 Stichting Res Fonds Pathologie Nachweis von invasivem krebs induziert von hpv und dessen vorläufer läsionen mit invasionspotential
KR100943525B1 (ko) * 2005-03-18 2010-02-22 (주)지노믹트리 바이오마커 스크리닝 시스템
AU2009224093A1 (en) * 2008-03-13 2009-09-17 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Cervical screening algorithms
CA2718092C (en) * 2008-03-21 2019-03-19 Oncomethylome Sciences S.A. Detection and prognosis of cervical cancer

Also Published As

Publication number Publication date
NZ588618A (en) 2012-10-26
JP2011519272A (ja) 2011-07-07
US9315866B2 (en) 2016-04-19
CA2721356A1 (en) 2009-10-22
HRP20130780T1 (hr) 2013-11-08
ES2425617T3 (es) 2013-10-16
CA2721356C (en) 2019-11-12
EP2283154B1 (en) 2013-05-22
PT2283154E (pt) 2013-08-29
JP5584197B2 (ja) 2014-09-03
AU2009236789A1 (en) 2009-10-22
US20110104660A1 (en) 2011-05-05
CN102105595A (zh) 2011-06-22
EP2283154A1 (en) 2011-02-16
WO2009128714A1 (en) 2009-10-22
AU2009236789B2 (en) 2014-10-09

Similar Documents

Publication Publication Date Title
DK2283154T3 (da) MAL- og CADM1-promotormethylering, molekylær diagnostisk markør for HPV-inducerede invasive livmoderhalscancere samt deres forstadielæsioner med høj malignitet
IL289062A (en) Molecular characterization of tumors
HK1212245A1 (en) Molecular marker for cancer stem cell
BR112012015337A2 (pt) terapia combinada para doença pulmonar obstrutiva crônica
HK1209460A1 (en) Prdm14 and fam19a4, molecular diagnostic markers for hpv-induced invasive cancers and their high-grade precursor lesions hpv prdm14 fam19a4
GB2459662B (en) Secure data cache
BRPI0916756A2 (pt) sistemas e métodos para anestesiar o tecido auricular.
EP2115161A4 (en) GENETIC METHYLATION IN THE DIAGNOSIS OF CANCERS
EP3101122C0 (en) GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES
IL202530A0 (en) Targeted nucleotide exchange with improved modified oligonucleotides
AP2011005929A0 (en) Substituted nucleoside and nucleotide analogs.
BRPI0908127A2 (pt) Método para o tratamento do câncer da próstata com degarelix antagonista do gnrh
BRPI0924981A2 (pt) vacinas para câncer cervical.
BR112012015334A2 (pt) terapia combinada para doença pulmonar obstrutiva crônica
GB0717101D0 (en) Tumour marker
EP2488123A4 (en) ELECTROSURGICAL PLENUM
BR112012001774A2 (pt) sistema de gerenciamento termico, veiculo associado
EP2346531A4 (en) TUMOR VACCINE
IT1396519B1 (it) Congegno di riscaldamento per testata di compressore
EP2137876A4 (en) VEHICLE SEGMENT CERTIFICATE MANAGEMENT USING NON-RELATED, SHORT-LIFE CERTIFICATE SYSTEMS
EP2421506A4 (en) NANOTRANT THERAPY FOR THE TREATMENT OF INVASIVE TUMORS
FR2948934B1 (fr) Grains d'alumine-zircone fondus.
ZA201200888B (en) New tumor marker
DK2285349T3 (da) Perfluorcarbonnanoemulsioner med endocytosefremmende overflade til genoverførsel
PL2289296T3 (pl) Półzawieszony obracalny pług z układem poprawiania właściwości trakcyjnych